Table of Contents Author Guidelines Submit a Manuscript
Advances in Bioinformatics
Volume 2016 (2016), Article ID 1373157, 16 pages
http://dx.doi.org/10.1155/2016/1373157
Research Article

Systematic Bioinformatic Approach for Prediction of Linear B-Cell Epitopes on Dengue E and prM Protein

Faculty of Medicine, General Sir John Kotelawala Defence University, 10390 Ratmalana, Sri Lanka

Received 29 February 2016; Revised 6 June 2016; Accepted 23 June 2016

Academic Editor: Ronak Y. Patel

Copyright © 2016 Mahesha N. Nadugala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Bhatt, P. W. Gething, O. J. Brady et al., “The global distribution and burden of dengue,” Nature, vol. 496, no. 7446, pp. 504–507, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Imrie, J. Meeks, A. Gurary et al., “Antibody to dengue 1 detected more than 60 years after infection,” Viral Immunology, vol. 20, no. 4, pp. 672–675, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. B. Halstead, J. S. Chow, and N. J. Marchette, “Immunological enhancement of dengue virus replication,” Nature: New Biology, vol. 243, no. 122, pp. 24–26, 1973. View at Google Scholar · View at Scopus
  4. B. D. Lindenbach, H. J. Thiel, and C. M. Rice, “Flaviviridae: the viruses and their replication,” in Fields Virology, D. M. Knipe and P. M. Howley, Eds., pp. 1101–1152, Lippincott William & Wilkins, Philadelphia, Pa, USA, 2007. View at Google Scholar
  5. R. J. Kuhn, W. Zhang, M. G. Rossmann et al., “Structure of dengue virus: implications for flavivirus organization, maturation, and fusion,” Cell, vol. 108, no. 5, pp. 717–725, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. F. A. Rey, F. X. Heinz, C. Mandl, C. Kunz, and S. C. Harrison, “The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution,” Nature, vol. 375, no. 6529, pp. 291–298, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Modis, S. Ogata, D. Clements, and S. C. Harrison, “A ligand-binding pocket in the dengue virus envelope glycoprotein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 12, pp. 6986–6991, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. W. D. Crill and J. T. Roehrig, “Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to vero cells,” Journal of Virology, vol. 75, no. 16, pp. 7769–7773, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Konishi and P. W. Mason, “Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein,” Journal of Virology, vol. 67, no. 3, pp. 1672–1675, 1993. View at Google Scholar · View at Scopus
  10. I. C. Lorenz, S. L. Allison, F. X. Heinz, and A. Helenius, “Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum,” Journal of Virology, vol. 76, no. 11, pp. 5480–5491, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Guirakhoo, R. A. Bolin, and J. T. Roehrig, “The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein,” Virology, vol. 191, no. 2, pp. 921–931, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. I.-M. Yu, H. A. Holdaway, P. R. Chipman, R. J. Kuhn, M. G. Rossmann, and J. Chen, “Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion,” Journal of Virology, vol. 83, no. 23, pp. 12101–12107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. I.-M. Yu, W. Zhang, H. A. Holdaway et al., “Structure of the immature dengue virus at low pH primes proteolytic maturation,” Science, vol. 319, no. 5871, pp. 1834–1837, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Dejnirattisai, A. Jumnainsong, N. Onsirisakul et al., “Cross-reacting antibodies enhance dengue virus infection in humans,” Science, vol. 328, no. 5979, pp. 745–748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Cardosa, S. M. Wang, M. S. H. Sum, and P. H. Tio, “Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses,” BMC Microbiology, vol. 2, article 9, 2002. View at Google Scholar · View at Scopus
  16. M. Beltramello, K. L. Williams, C. P. Simmons et al., “The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity,” Cell Host & Microbe, vol. 8, no. 3, pp. 271–283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Sukupolvi-Petty, S. K. Austin, W. E. Purtha et al., “Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes,” Journal of Virology, vol. 81, no. 23, pp. 12816–12826, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. G. D. Gromowski, N. D. Barrett, and A. D. T. Barrett, “Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus,” Journal of Virology, vol. 82, no. 17, pp. 8828–8837, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H.-E. Lin, W.-Y. Tsai, I.-J. Liu et al., “Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay,” PLoS Neglected Tropical Diseases, vol. 6, no. 1, Article ID e1447, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. H.-C. Wu, M.-Y. Jung, C.-Y. Chiu et al., “Identification of a dengue virus type 2 (DEN-2) serotype-specific B-cell epitope and detection of DEN-2-immunized animal serum samples using an epitope-based peptide antigen,” Journal of General Virology, vol. 84, no. 10, pp. 2771–2779, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Khan, O. Miotto, A. T. Heiny et al., “A systematic bioinformatics approach for selection of epitope-based vaccine targets,” Cellular Immunology, vol. 244, no. 2, pp. 141–147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. A. Reche, E. Fernandez-Caldas, D. R. Flower, M. Fridkis-Hareli, and Y. Hoshino, “Peptide-based immunotherapeutics and vaccines,” Journal of Immunology Research, vol. 2014, Article ID 256784, 2 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. E. P. Larsen, O. Lund, and M. Nielsen, “Improved method for predicting linear B-cell epitopes,” Immunome Research, vol. 2, article 2, 2006. View at Google Scholar
  24. J. M. R. Parker, D. Guo, and R. S. Hodges, “New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites,” Biochemistry, vol. 25, no. 19, pp. 5425–5432, 1986. View at Publisher · View at Google Scholar · View at Scopus
  25. J. V. Ponomarenko, H.-H. Bui, W. Li et al., “ElliPro: a new structure-based tool for the prediction of antibody epitopes,” BMC Bioinformatics, vol. 9, article 514, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Thornton, M. S. Edwards, W. R. Taylor, and D. J. Barlow, “Location of ‘continuous’ antigenic determinants in the protruding regions of proteins,” The EMBO journal, vol. 5, no. 2, pp. 409–413, 1986. View at Google Scholar · View at Scopus
  27. N. W. B. Eswar, M. A. Marti-Renom, M. S. Madhusudhan et al., “UNIT 2.9 comparative protein structure modeling using MODELLER,” Current Protocols in Protein Science, vol. 50, pp. 2.9.1–2.9.31, 2007. View at Publisher · View at Google Scholar
  28. B. Yao, L. Zhang, S. Liang, and C. Zhang, “SVMTriP: a method to predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity,” PLoS ONE, vol. 7, no. 9, Article ID e45152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-H. Bui, J. Sidney, W. Li, N. Fusseder, and A. Sette, “Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines,” BMC Bioinformatics, vol. 8, article 361, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. G. E. Crooks, G. Hon, J.-M. Chandonia, and S. E. Brenner, “WebLogo: a sequence logo generator,” Genome Research, vol. 14, no. 6, pp. 1188–1190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. X.-Q. Li, L.-W. Qiu, Y. Chen et al., “Dengue virus envelope domain III immunization elicits predominantly cross-reactive, poorly neutralizing antibodies localized to the AB loop: implications for dengue vaccine design,” Journal of General Virology, vol. 94, no. 10, pp. 2191–2201, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Cologna and R. Rico-Hesse, “American genotype structures decrease dengue virus output from human monocytes and dendritic cells,” Journal of Virology, vol. 77, no. 7, pp. 3929–3938, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Luo, X. Guo, H. Yan et al., “Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM,” Applied Microbiology and Biotechnology, vol. 99, no. 14, pp. 5917–5927, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Y. Song, H. Zaho, S. H. Li et al., “Identification and characterization of a linearized B-cell epitope on the pr protein of dengue virus,” Journal of General Virology, vol. 94, part 7, pp. 1510–1516, 2013. View at Publisher · View at Google Scholar
  35. J. T. Roehrig, R. A. Bolin, and R. G. Kelly, “Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica,” Virology, vol. 246, no. 2, pp. 317–328, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. Y.-Y. Luo, J.-J. Feng, J.-M. Zhou et al., “Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody,” BMC Microbiology, vol. 13, no. 1, article 194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Costin, E. Zaitseva, K. M. Kahle et al., “Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop,” Journal of Virology, vol. 87, no. 1, pp. 52–66, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S. A. Smith, A. R. de Alwis, N. Kose et al., “The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein,” mBio, vol. 4, no. 6, Article ID e00873-13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. S. L. Allison, K. Stiasny, K. Stadler, C. W. Mandl, and F. X. Heinz, “Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E,” Journal of Virology, vol. 73, no. 7, pp. 5605–5612, 1999. View at Google Scholar · View at Scopus
  40. A. K. I. Falconar, “Use of synthetic peptides to represent surface-exposed epitopes defined by neutralizing dengue complex- and flavivirus group-reactive monoclonal antibodies on the native dengue type-2 virus envelope glycoprotein,” Journal of General Virology, vol. 89, no. 7, pp. 1616–1621, 2008. View at Publisher · View at Google Scholar · View at Scopus